http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Surgalign Announces First Quarter 2023 Results and Provides Update on its Business Operations
-
Surgalign Announces Release of HOLO™ AI Insights for Neurovascular Research
-
Surgalign Schedules First Quarter 2023 Earnings Release for May 11, 2023
-
Surgalign To Collaborate with Dr. Alexander Vaccaro and Dr. Pierce Nunley to Advance HOLO™ AI Insights and its Artificial Intelligence Technologies
-
Surgalign Announces Receipt of Nasdaq Deficiency Notice and Intends to Submit Plan to Regain Compliance
-
Surgalign Announces Receipt of Nasdaq Deficiency Notice and Intends to Submit Plan to Regain Compliance
-
Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2022 Results
-
Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2022 Results
-
Surgalign Schedules Fourth Quarter and Full Year 2022 Earnings Release for March 30, 2023
-
Surgalign Schedules Fourth Quarter and Full Year 2022 Earnings Release for March 30, 2023
-
Surgalign Launches Next Generation Software for its HOLO Portal™ Surgical Guidance System and Expands Surgical Tool Integration to Drive Use Case Adoption
-
Surgalign Launches Next Generation Software for its HOLO Portal™ Surgical Guidance System and Expands Surgical Tool Integration to Drive Use Case Adoption
-
Surgalign to Host its 2023 Annual Meeting of Shareholders on June 1, 2023
-
Surgalign to Host its 2023 Annual Meeting of Shareholders on June 1, 2023
-
Surgalign Announces Release of HOLO™ AI Insights for Spine Imaging
-
Surgalign Announces Release of HOLO™ AI Insights for Spine Imaging
-
Surgalign (SRGA) Provides Update on Corporate Restructuring Initiatives and Confirms its Prior 2022 Revenue Guidance
-
Surgalign Provides Update on Corporate Restructuring Initiatives and Confirms its Prior 2022 Revenue Guidance
-
Surgalign Provides Update on Corporate Restructuring Initiatives and Confirms its Prior 2022 Revenue Guidance
-
Surgalign to Participate at the 2023 AAOS Annual Meeting OrthoDome in Las Vegas
-
Surgalign to Participate at the 2023 AAOS Annual Meeting OrthoDome in Las Vegas
-
Medical City Frisco is the Latest Hospital to Utilize Surgalign’s HOLO Portal Surgical Guidance System
-
Medical City Frisco is the Latest Hospital to Utilize Surgalign’s HOLO Portal Surgical Guidance System
-
Xtant Medical (XTNT) Acquires Coflex Product Line from Surgalign (SRGA) for $17 Million
-
Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million
-
Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million
-
Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million
-
Surgalign Announces 100th Case Completed Utilizing its Recently Launched Cortera™ Spinal Fixation System
-
Surgalign Announces 100th Case Completed Utilizing its Recently Launched Cortera™ Spinal Fixation System
-
Surgalign Holdings (SRGA) announced additional commercialization of its HOLO Portal surgical guidance system
-
Surgalign™ Expands Adoption of its HOLO Portal™ Surgical Guidance System in Virginia
-
Surgalign™ Expands Adoption of its HOLO Portal™ Surgical Guidance System in Virginia
-
Surgalign Announces Closing of $12.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Surgalign Announces Closing of $12.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Surgalign Holdings (SRGA) Prices 6M Share Direct Offering at $2/sh
-
Surgalign Announces $12.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Surgalign Announces $12.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Surgalign Holdings (SRGA) Announces Corporate Restructuring Program to Focus on Key Growth Areas
-
Surgalign™ Announces Corporate Restructuring Program to Focus on Key Growth Areas
-
Surgalign™ Announces Corporate Restructuring Program to Focus on Key Growth Areas
-
Surgalign Announces Third Quarter 2022 Results and Provides Update on Business Operations and Financial Outlook
-
Surgalign Announces Third Quarter 2022 Results and Provides Update on Business Operations and Financial Outlook
-
Surgalign Schedules Third Quarter 2022 Earnings Release for November 2, 2022
-
Surgalign Schedules Third Quarter 2022 Earnings Release for November 2, 2022
-
Surgalign™ Awarded 2022 Best New Technology Award from Orthopedics This Week for its HOLO Portal™ Surgical Guidance System
-
Surgalign™ Awarded 2022 Best New Technology Award from Orthopedics This Week for its HOLO Portal™ Surgical Guidance System
-
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
Surgalign Launches Portfolio of Fortilink® with TiPlus™ Technology Products, Expanding its Addressable Market for Interbody Fusion Procedures
-
Surgalign Launches Portfolio of Fortilink® with TiPlus™ Technology Products, Expanding its Addressable Market for Interbody Fusion Procedures

